Flaws Found in Compendia for Dermatology Conditions, JAMA Study Suggests

The two compendia that Medicare Part D recognizes to make coverage determinations for off-label prescribing were “incomplete, outdated, idiosyncratic, and unpredictable” for some chronic dermatologic conditions, according to findings recently published in JAMA Dermatology.